Moderna seeks FDA approval for 4th dose of Covid shot

The drugmaker has asked the Modern Food and Drug Administration to approve a fourth shot of its COVID-19 vaccine as a booster dose for all adults.

WASHINGTON – Pharmaceutical maker Moderna on Thursday asked the Food and Drug Administration to approve a fourth shot of its COVID-19 vaccine as a booster dose for all adults.

The request extends beyond the regulator’s request to rival pharmaceutical company Pfizer to allow a booster shot for all seniors earlier this week.

In a press release, the agency said its request for approval was made to “give flexibility” to all adults to determine “appropriate use” of the second booster dose of the mRNA vaccine by the Centers for Disease Control and Prevention and medical providers “due to age or tolerance to COVID.” There is a high risk of 19 including them. “

Moderna said her request for an additional dose was “based on recently published data from the United States and Israel following the rise of Omicron.”

On Tuesday, Pfizer and its partner Bioentech asked U.S. regulators to approve an additional booster dose of their Covid-19 vaccine for adults, according to Israeli data, which would benefit older adults.

Leave a Comment